FOUNDATIONS OF COST-EFFECTIVENESS ANALYSIS FOR HEALTH AND MEDICAL PRACTICES

被引:1499
作者
WEINSTEIN, MC [1 ]
STASON, WB [1 ]
机构
[1] HARVARD UNIV,CTR ANAL HLTH PRACTICES,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1056/NEJM197703312961304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:716 / 721
页数:6
相关论文
共 23 条
[1]  
ACTON JP, 1973, R950RC RAND CORP REP
[2]  
ACTON JP, 1975, R1697NHLI RAND CORP
[3]  
Bunker J.P., 1974, BENEFITS RISKS MEDIC, P85
[4]  
BUNKER JP, 1977, COSTS RISKS BENEFITS
[5]  
Bush J.W., 1973, HLTH STATUS INDEXES
[6]  
Chase S.B, 1968, PROBLEMS PUBLIC EXPE, P127, DOI DOI 10.1037/12069-015
[7]   PROTECTING MEDICAL COMMONS - WHO IS RESPONSIBLE [J].
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (05) :235-241
[8]  
Klarman H.E., 1965, MEASURING BENEFITS G, P367
[9]  
KLARMAN HE, 1973, HSM733016 DHEW PUBL
[10]   MEASURES OF CLINICAL EFFICACY - COST-EFFECTIVENESS CALCULATIONS IN DIAGNOSIS AND TREATMENT OF HYPERTENSIVE RENOVASCULAR DISEASE [J].
MCNEIL, BJ ;
VARADY, PD ;
BURROWS, BA ;
ADELSTEIN, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (05) :216-221